Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Clearside Biomedical, Inc. (CLSD : NSDQ)

• Company Description    Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia. Number of Employees: 34

• Price / Volume Information    Yesterday's Closing Price: $1.45 Daily Weekly Monthly 20 Day Moving Average: 287,305 shares Shares Outstanding: 60.15 (millions) Market Capitalization: $87.22 (millions) Beta: 2.15 52 Week High: $7.73 52 Week Low: $1.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.65% -1.61% 12 Week -0.68% 9.19% Year To Date -47.27% -35.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 900 NORTH POINT PARKWAY SUITE 200 - ALPHARETTA,GA 30005 USA ph: 678-270-3631 fax: 678-270-4033 ir@clearsidebio.com http://www.clearsidebio.com

• General Corporate Information    Officers George Lasezkay - President; Chief Executive Officer and Director Charles A. Deignan - Chief Financial Officer Christy L. Shaffer - Director Clay B. Thorp - Director Benjamin R. Yerxa - Director Peer Information Clearside Biomedical, Inc. (CORR.) Clearside Biomedical, Inc. (RSPI) Clearside Biomedical, Inc. (CGXP) Clearside Biomedical, Inc. (BGEN) Clearside Biomedical, Inc. (GTBP) Clearside Biomedical, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 185063104 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 60.15 Most Recent Split Date: (:1) Beta: 2.15 Market Capitalization: $87.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.75 Price/Cash Flow: 156.17 Price / Sales: 2.92 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -141.94% Sales Growth vs. Year Ago Period: 920.59% vs. Previous Quarter: -98.65% ROE 03/31/22 - 0.31 12/31/21 - 1.63 09/30/21 - -161.73 ROA 03/31/22 - 0.25 12/31/21 - 1.19 09/30/21 - -98.71 Current Ratio 03/31/22 - 8.49 12/31/21 - 9.08 09/30/21 - 2.90 Quick Ratio 03/31/22 - 8.49 12/31/21 - 9.08 09/30/21 - 2.90 Operating Margin 03/31/22 - 0.28 12/31/21 - 1.27 09/30/21 - -652.60 Net Margin 03/31/22 - 0.28 12/31/21 - 1.27 09/30/21 - -652.60 Pre-Tax Margin 03/31/22 - 0.28 12/31/21 - 1.27 09/30/21 - -652.60 Book Value 03/31/22 - 0.53 12/31/21 - 0.64 09/30/21 - 0.30 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©